1. Avocados: Mexico’s green gold, drug cartel violence and the U.S. opioid crisis. (2025). de Haro, Itzel.
   In: World Development.
   RePEc:eee:wdevel:v:191:y:2025:i:c:s0305750x25000257.

   Full description at Econpapers || Download paper

2. Electronic prescription monitoring and the opioid epidemic. (2022). Liu, Jiayi ; Kim, Ti Tongil ; Kc, Diwas.
   In: Production and Operations Management.
   RePEc:bla:popmgt:v:31:y:2022:i:11:p:4057-4074.

   Full description at Econpapers || Download paper

1. Ali, M. M., W. N. Dowd, T. Classen, R. Mutter, and S. P. Novak. 2017. “Prescription Drug Monitoring Programs, Nonmedical Use of Prescription Drugs, and Heroin Use: Evidence from the National Survey of Drug Use and Health.” Addictive Behaviors 69: 65–77.
   Paper not yet in RePEc: Add citation now
   

2. Alpert, A., D. Powell, and R. L. Pacula. 2018. “Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids.” American Economic Journal: Economic Policy 10 (4): 1–35.

3. Borgschulte, M., A. Corredor-Waldron, and G. Marshall. 2018. “A Path Out: Prescription Drug Abuse, Treatment, and Suicide.” Journal of Economic Behavior and Organization 149: 169–84.

4. Buchmueller, T. C., and C. Carey. 2018. “The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare.” American Economic Journal: Economic Policy 10 (1): 77–112.

5. Carpenter, C. S., C. B. McClellan, and D. I. Rees. 2017. “Economic Conditions, Illicit Drug Use, and Substance Use Disorders in the United States.” Journal of Health Economics 52 (C): 63–73.

6. Case, A., and A. Deaton. 2015. “Rising Morbidity and Mortality in Midlife Among White Nonhispanic Americans in the 21st Century.” Proceedings of the National Academy of Sciences 112 (49): 15078–83.

7. Case, A., and A. Deaton. 2017. “Mortality and Morbidity in the 21st Century.” Brookings Papers on Economic Activity 2017: 1–397.
   Paper not yet in RePEc: Add citation now
   
8. Centers for Disease Control and Prevention. 2017. Annual Surveillance Drug-Related Risks and Outcomes. United States Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
   Paper not yet in RePEc: Add citation now
   
9. Charles, K. K., E. Hurst, and M. Schwartz. 2018. The Transformation of Manufacturing and the Decline in U.S. Employment. NBER Working Paper Series No. 24468.
   Paper not yet in RePEc: Add citation now
   
10. Cicero, T. J., and J. A. Inciardi. 2005. “Diversion and Abuse of Methadone Prescribed for Pain Management.” Journal of American Medical Association 293 (3): 293–8.
    Paper not yet in RePEc: Add citation now
    

11. Clayton, D. H. 2019. “The Effect of Prescription Drug Coverage on Mortality: Evidence from Medicaid Implementation.” Journal of Health Economics 63: 100–13.

12. Dave, D., M. Deza, and B. P. Horn. 2018. Prescription Drug Monitoring Programs, Opioid Abuse, and Crime. NBER Working Paper Series No. 24975.

13. Davis, C. S. 2017. “Commentary on Pardo (2017) and Moyo et al. (2017): Much Still Unknown about Prescription Drug Monitoring Programs.” Addiction 112 (10): 1797–8.
    Paper not yet in RePEc: Add citation now
    
14. Davis, C. S., and D. Carr. 2015. “Legal Changes to Increase Access to Naloxone for Opioid Overdose Reversal in the United States.” Drug and Alcohol Dependence 157: 112–20.
    Paper not yet in RePEc: Add citation now
    

15. Dobkin, C., and N. Nicosia. 2009. “The War on Drugs: Methamphetamine, Public Health, and Crime.” American Economic Review 99 (1): 324–49.

16. Dobkin, C., N. Nicosia, and M. Weinberg. 2014. “Are Supply-Side Drug Control Efforts Effective? Evaluating OTC Regulations Targeting Methamphetamine Precursors.” Journal of Public Economics 120: 48–61.

17. Doleac, J. L., and A. Mukherjee. 2018. The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime. IZA Discussion Papers No. 11489.

18. Fryer, R. G., P. S. Heaton, S. D. Levitt, and K. M. Murphy. 2013. “Measuring Crack Cocaine and its Impact.” Economic Inquiry 51 (3): 1651–81.

19. Ghosh, A., K. Simon, and B. D. Sommers. 2019. “The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults: Evidence from Recent Medicaid Expansions.” Journal of Health Economics 63: 64–80.

20. Gihleb, R., O. Giuntella, and N. Zhang. 2020a. “Prescription Drug Monitoring Programs and Neonatal Outcomes.” Regional Science and Urban Economics 81: 103497.
    Paper not yet in RePEc: Add citation now
    
21. Gihleb, R., O. Giuntella, and N. Zhang. 2020b. “The Effects of Mandatory Prescription Drug Monitoring Programs on Foster Care Admissions.” Journal of Human Resources (forthcoming).
    Paper not yet in RePEc: Add citation now
    

22. Goodman-Bacon, A. 2018. Difference-in-Differences with Variation in Treatment Timing. NBER Working Paper Series No. 25018.

23. Goodman-Bacon, A., T. Goldring, and A. Nichols. 2019. “bacondecomp: Stata Module for Decomposing Difference-in-Differences Estimation with Variation in Treatment Timing.” https://ideas.repec.org/c/boc/bocode/s458676.html.
    Paper not yet in RePEc: Add citation now
    

24. Grecu, A. M., D. M. Dave, and H. Saffer. 2019. “Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse.” Journal of Policy Analysis and Management 38 (1): 181–209.

25. Haegerich, T. M., L. J. Paulozzi, B. J. Manns, and C. M. Jones. 2014. “What We Know, and Don’t Know, about the Impact of State Policy and Systems-Level Interventions on Prescription Drug Overdose.” Drug and Alcohol Dependence 145: 34–47.
    Paper not yet in RePEc: Add citation now
    

26. Harris, M. C., L. M. Kessler, M. N. Murray, and B. Glenn. 2020. “Prescription Opioids and Labor Market Pains: The Effect of Schedule II Opioids on Labor Force Participation and Unemployment.” Journal of Human Resources 55 (4): 1319–64.

27. Hedegaard, H., M. Warner, and A. M. Miniño. 2017. Drug Overdose Deaths in the United States, 1999–2015. NCHS Data Brief No. 294.
    Paper not yet in RePEc: Add citation now
    
28. Helmerhorst, G., T. Teunis, S. Janssen, and D. Ring. 2017. “An Epidemic of the Use, Misuse and Overdose of Opioids and Deaths Due to Overdose, in the United States and Canada: Is Europe Next?” The Bone & Joint Journal 99 (7): 856–64.
    Paper not yet in RePEc: Add citation now
    

29. Horwitz, J., C. S. Davis, L. S. McClelland, R. S. Fordon, and E. Meara. 2018. The Problem of Data Quality in Analyses of Opioid Regulation: The Case of Prescription Drug Monitoring Programs. NBER Working Paper Series No. 24947.

30. Joyce, R., and X. Xu. 2019. Inequalities in the Twenty-First Century: Introducing the IFS Deaton Review. Technical Report.
    Paper not yet in RePEc: Add citation now
    
31. Kilby, A. E. 2015. Opioids for the Masses: Welfare Tradeoffs in the Regulation of Narcotic Pain Medications. Mimeo. http://economics.mit.edu/files/11150 (accessed January 18, 2021).
    Paper not yet in RePEc: Add citation now
    
32. Mallatt, J. 2017. The Effect of Prescription Drug Monitoring Programs on Opioid Prescriptions and Heroin Crime Rates. Mimeo. http://dx.doi.org/10.2139/ssrn.3050692 (accessed January 18, 2021).
    Paper not yet in RePEc: Add citation now
    
33. McCabe, S. E., J. A. Cranford, and C. J. Boyd. 2006. “The Relationship Between Past-Year Drinking Behaviors and Nonmedical Use of Prescription Drugs: Prevalence of Co-occurrence in a National Sample.” Drug and Alcohol Dependence 84 (3): 281–8.
    Paper not yet in RePEc: Add citation now
    
34. Meara, E., and J. Skinner. 2015. “Losing Ground at Midlife in America.” Proceedings of the National Academy of Sciences 112 (49): 15006–7.
    Paper not yet in RePEc: Add citation now
    
35. Meara, E., J. R. Horwitz, W. Powell, L. McClelland, W. Zhou, A. J. O’Malley, and N. E. Morden. 2016. “State Legal Restrictions and Prescription-Opioid Use Among Disabled Adults.” New England Journal of Medicine 375: 44–53.
    Paper not yet in RePEc: Add citation now
    
36. Meinhofer, A. 2017. The War on Drugs: Estimating the Effect of Prescription Drug Supply-Side Interventions. Mimeo. http://dx.doi.org/10.2139/ssrn.2716974 (accessed January 18, 2021).
    Paper not yet in RePEc: Add citation now
    
37. Paulozzi, L. J. 2012. “Prescription Drug Overdoses: A Review.” Journal of Safety Research 43 (4): 283–9.
    Paper not yet in RePEc: Add citation now
    
38. Paulozzi, L. J., E. M. Kilbourne, and H. A. Desai. 2011. “Prescription Drug Monitoring Programs and Death Rates from Drug Overdose.” Pain Medicine 12 (5): 747–54.
    Paper not yet in RePEc: Add citation now
    

39. Pei, Z., J.-S. Pischke, and H. Schwandt. 2019. “Poorly Measured Confounders Are More Useful on the Left Than on the Right.” Journal of Business & Economic Statistics 37 (2): 205–16.

40. Peirce, G. L., M. J. Smith, M. A. Abate, and J. Halverson. 2012. “Doctor and Pharmacy Shopping for Controlled Substances.” Medical Care 50: 494–500.
    Paper not yet in RePEc: Add citation now
    

41. Pierce, J. R., and P. K. Schott. 2020. “Trade Liberalization and Mortality: Evidence from US Counties.” American Economic Review: Insights 2 (1): 47–64.

42. Popovici, I., J. C. Maclean, B. Hijazi, and S. Radakrishnan. 2017. “The Effect of State Laws Designed to Prevent Nonmedical Prescription Opioid Use on Overdose Deaths and Treatment.” Health Economics 27: 1–12.
    Paper not yet in RePEc: Add citation now
    

43. Powell, D., R. L. Pacula, and E. Taylor. 2015. How Increasing Medical Access toOpioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D. NBER Working Paper Series No. 21072.

44. Powell, D., R. L. Pacula, and M. Jacobson. 2018. “Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?” Journal of Health Economics 58: 29–42.

45. Ruhm, C. J. 2018. Deaths of Despair or Drug Problems? NBER Working Paper Series No. 24188.

46. Stiglitz, J. E. 2015. When Inequality Kills. Project Syndicate.
    Paper not yet in RePEc: Add citation now
    
47. The Intended and Unintended Effects of Opioid Policies Krueger, A. 2017. “Where Have All the Workers Gone: An Inquiry into the Decline of the U.S. Labor Force Participation Rate.” Brookings Papers on Economic Activity Fall 2017: 1–87.
    Paper not yet in RePEc: Add citation now
    
48. UCR. 2000. Uniform Crime Reporting Program Data United States: County-Level Detailed Arrest and Offense Data. ICPSR (3451).
    Paper not yet in RePEc: Add citation now
    
49. Yang, Z., B. Wilsey, M.Bohm, M. Weyrich, K.Roy, D. Ritley, C.Jones,and J. Melnikow. 2015. “Defining Risk of Prescription Opioid Overdose: Pharmacy Shopping and Overlapping Prescriptions Among Long-Term Opioid Users in Medicaid.” The Journal of Pain 16 (5): 445–53.
    Paper not yet in RePEc: Add citation now
    
50. Zhou, C., C. S. Florence, and D. Dowell. 2016. “Payments for Opioids Shifted Substantially to Public and Private Insurers while Consumer Spending Declined, 1999–2012.” Health Affairs 35 (5): 824–31. 792 C. Deiana and L. Giua
    Paper not yet in RePEc: Add citation now
    

1. Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare. (2023). Simon, Kosali ; Maclean, Johanna ; Cantor, Jonathan H ; Taylor, Erin ; Agniel, Denis.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:31884.

   Full description at Econpapers || Download paper

2. Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior. (2022). Grooms, Jevay ; Ellyson, Alice M ; Ortega, Alberto.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341.

   Full description at Econpapers || Download paper

3. Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21. (2022). Mulligan, Casey.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:29719.

   Full description at Econpapers || Download paper

4. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp15221.

   Full description at Econpapers || Download paper

5. Opioids and the Labor Market. (2022). Schweitzer, Mark ; Fee, Kyle ; Aliprantis, Dionissi.
   In: Working Papers.
   RePEc:fip:fedcwq:180702.

   Full description at Econpapers || Download paper

6. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: CESifo Working Paper Series.
   RePEc:ces:ceswps:_9704.

   Full description at Econpapers || Download paper

7. Are prescription drug monitoring laws effective for all? Evidence from administrative data. (2022). Gupta, Sumedha ; al Achkar, Morhaf ; Ray, Bradley.
   In: Contemporary Economic Policy.
   RePEc:bla:coecpo:v:40:y:2022:i:1:p:28-47.

   Full description at Econpapers || Download paper

8. Information Avoidance and Celebrity Exposure: The Effect of Magic Johnson on AIDS Diagnoses and Mortality in the U.S.. (2021). Martin, Joshua ; Rodriguez, Zachary ; Cardazzi, Alexander.
   In: Working Papers.
   RePEc:wvu:wpaper:21-04.

   Full description at Econpapers || Download paper

9. Prescription drug monitoring programs, opioid abuse, and crime. (2021). Horn, Brady ; Deza, Monica ; Dave, Dhaval.
   In: Southern Economic Journal.
   RePEc:wly:soecon:v:87:y:2021:i:3:p:808-848.

   Full description at Econpapers || Download paper

10. The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity. (2021). Wang, Lucy Xiaolu.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:9:p:2026-2046.

    Full description at Econpapers || Download paper

11. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

12. Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation. (2021). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29574.

    Full description at Econpapers || Download paper

13. Illicit Drugs and the Decline of the Middle Class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14035.

    Full description at Econpapers || Download paper

14. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

15. Thinking outside the box: The cross-border effect of tax cuts on R&D. (2021). Schwab, Thomas ; Todtenhaupt, Maximilian.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:204:y:2021:i:c:s0047272721001729.

    Full description at Econpapers || Download paper

16. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

17. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. (2021). Hollingsworth, Alex ; Nguyen, Thuy ; Simon, Kosali ; Sacks, Daniel W.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629620310432.

    Full description at Econpapers || Download paper

18. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. (2021). Kim, Bo Kyung.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:75:y:2021:i:c:s0167629620310547.

    Full description at Econpapers || Download paper

19. Illicit drugs and the decline of the middle class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:183:y:2021:i:c:p:718-743.

    Full description at Econpapers || Download paper

20. Designing interagency responses to wicked problems: Creating a common, cross-agency understanding. (2021). Sydelko, Pamela ; Midgley, Gerald ; Espinosa, Angela.
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:294:y:2021:i:1:p:250-263.

    Full description at Econpapers || Download paper

21. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

22. The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime. (2021). Giua, Ludovica ; Ludovica, Giua ; Claudio, Deiana.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:21:y:2021:i:2:p:751-792:n:11.

    Full description at Econpapers || Download paper

23. Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses. (2021). d'Este, Rocco.
    In: Economica.
    RePEc:bla:econom:v:88:y:2021:i:349:p:208-233.

    Full description at Econpapers || Download paper

24. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

25. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. (2020). Buchmueller, Thomas C ; Meille, Giacomo ; Carey, Colleen M.
    In: Health Economics.
    RePEc:wly:hlthec:v:29:y:2020:i:9:p:957-974.

    Full description at Econpapers || Download paper

26. Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucn:wpaper:202025.

    Full description at Econpapers || Download paper

27. Drugs on the Web, Crime in the Streets. The impact of Dark Web marketplaces on street crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucd:wpaper:202009.

    Full description at Econpapers || Download paper

28. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

29. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. (2020). Simon, Kosali ; Gupta, Sumedha ; Nguyen, Thuy D ; Freeman, Patricia R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27520.

    Full description at Econpapers || Download paper

30. Three Myths about Federal Regulation. (2020). Mulligan, Casey ; McLaughlin, Patrick A.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27233.

    Full description at Econpapers || Download paper

31. Paid sick-leave and physical mobility: Evidence from the United States during a pandemic. (2020). Simon, Kosali ; Pesko, Michael ; Maclean, Johanna ; Andersen, Martin.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27138.

    Full description at Econpapers || Download paper

32. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

33. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26812.

    Full description at Econpapers || Download paper

34. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2020-10.

    Full description at Econpapers || Download paper

35. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13395.

    Full description at Econpapers || Download paper

36. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

37. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

38. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

39. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. (2020). Powell, David ; Pacula, Rosalie ; Taylor, Erin.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303029.

    Full description at Econpapers || Download paper

40. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey B.
    In: Working Papers.
    RePEc:bfi:wpaper:2020-10.

    Full description at Econpapers || Download paper

41. Shackling the Identification Police?. (2019). Ruhm, Christopher.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:85:y:2019:i:4:p:1016-1026.

    Full description at Econpapers || Download paper

42. Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. (2019). Wettstein, Gal.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:5:p:666-677.

    Full description at Econpapers || Download paper

43. Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin. (2019). Beheshti, David.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:12:p:1449-1461.

    Full description at Econpapers || Download paper

44. How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs. (2019). Simon, Kosali ; Bradford, W. David ; Nguyen, Thuy D.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26356.

    Full description at Econpapers || Download paper

45. Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. (2019). Simon, Kosali ; Hollingsworth, Alex ; Nguyen, Thuy D ; Sacks, Daniel W.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25974.

    Full description at Econpapers || Download paper

46. A novel supply-side measure to combat abuse of addictive prescription drugs. (2019). Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2019_11.

    Full description at Econpapers || Download paper

47. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Bockerman, Petri ; Saxell, Tanja.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12275.

    Full description at Econpapers || Download paper

48. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Saxell, Tanja ; Bockerman, Petri.
    In: Working Papers.
    RePEc:fer:wpaper:117.

    Full description at Econpapers || Download paper

49. Drivers of the fatal drug epidemic. (2019). Ruhm, Christopher.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:64:y:2019:i:c:p:25-42.

    Full description at Econpapers || Download paper

50. Shackling the Identification Police?. (2018). Ruhm, Christopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25320.

    Full description at Econpapers || Download paper

Report date: 2025-09-21 01:53:55 || Missing content? Let us know